This activity is expired and is no longer available for CME credit.


Neovascular Age-Related Macular Degeneration: Insights Into Achieving Longer Duration of Treatment

Author(s)/Faculty: Sophie J. Bakri, MD; Nancy M. Holekamp, MD; Arshad M. Khanani, MD, MA
Release Date: 12/16/2019Expiration Date: 12/15/2020
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of patients with neovascular age-related macular degeneration (nAMD). However, it has also introduced new problems—notably patients’ treatment burden of undergoing frequent intraocular injections. Continuing research on the use of various treatment regimens and on emerging anti-VEGF medications suggests opportunities to optimize nAMD therapy and better balance reductions in treatment frequency with achieving and maintaining improvements in visual acuity. In this educational activity, expert faculty examine the burden of current anti-VEGF treatment protocols as well as the latest clinical trial data on investigational anti-VEGF agents and their mechanisms of action.